info@ngageittec.com

nGageIT Connected NanoSmart Devices

We Make Taking Your Medicine A Digital Experience

WORLD’S FIRST ‘INGESTIBLE NANO BAR CODES’ AND INTELLIGENT INJECTION SENSORS

nGageIT Develops Health Care Solutions that Make Medicines Smarter, Easier to Use & to Monitor

With over 15 trillion doses of medications in the global supply chain and a substantially related number of disconnected patients – nGageIT aims to connect them all.

 

 

 

 nGageIT Digital Health Solutions is creating groundbreaking new nano-enabled technology and sensor platforms that promise to transform digital heath care by verifying that medications are ingested or injected correctly, and on schedule, using a smart phone.

 

 

 

 

 

 

 

 

 

 

 

 

 

“Low medication adherence is arguably the most significant problem in our health care ecosystem, costing over $300 billion dollars in the U.S. alone and leading to over 125,000 premature deaths each year,”

said nGageIT Co-Founder Dr. Jennifer Murdoch, an expert in health systems.

 “The faster we get this out on the market, the more people we can help.”

nGageIT’s sensor technologies monitor when patients take either oral medications or give themselves medical injections at home. This data is automatically uploaded to the cloud through the patient’s smart phone and can be tracked in real-time by health care providers and in clinical trials. This leads to better compliance with medical advice and medical device use, and better health outcomes for the patient.

 

 

Patients taking high value medications for serious conditions such as breast cancer or rare orphan diseases can now rely on nGageIT’s predictive dosing system to verify the ingestion of medication and seamlessly automate complex dosing schedules. Physicians are empowered by the medication usage data to precisely customize therapy to a patient’s lifestyle, behavior or genes.

nGageIT’s NanoSmart oral encoding platform turns any approved oral dosage into a digital object. nGageIT’s NanoSmart Biosensor can detect a single, digitally encoded nanoparticle from the more than 2,500 substances in the human breath. The biosensor detects digitally encoded nanoparticles using food grade safe NanoSmart particles, reading them like an “ingestible bar code” from a detection device called the Noz. nGageIT’s platform does not require cumbersome sensor patches to be worn – the patient would simply breathe.

The NanoSmart encoding particles can be safely integrated into current oral dosage coatings used by pharmaceutical manufacturers, minimizing any supply chain disruptions. A compatible app then provides information on dosage and sends automated reminders to the patient. The patient can connect to their healthcare provider through video or live chat as needed.

nGageIT has also developed smart injection devices called iSenz and InsuloSenz that safely and non-invasively detect that proper doses of medication have been injected. nGageIT is the only company in the world that has developed devices that can scan and detect that medication has been injected below the skin, confirm the proper angle of the injection and verify its quality.

“With approximately 1.4 million new cases of diabetes diagnosed in the U.S. each year, smart tools like the iSenz and the InsuloSenz are helping patients inject with confidence,”

said Dr. Murdoch of nGageIT Health Solutions.

 

 

The InsuloSenz Smart Injector is for more than just insulin delivery – it is a powerful tool designed to enhance diabetic care. InsuloSenz is customized to diabetics and guides the diabetic patient to inject insulin through flashing blue for the correct angle of injection, or red for an incorrect angle. By proactively correcting the injection angle, sub-optimal dosing can be prevented in diabetic patients, making diabetics free to “inject, detect and go.” The InsuloSenz sensor is also being developed to help diabetics determine the best place on the body to inject to prevent complications and poor absorption.

 

 

“Can you imagine having to take a shot four times a day and remember to do it on time and do it correctly?”

“We certainly can’t. Current insulin pens on the market are not all that smart — it’s like having cruise control but you still have to work the peddles on your car and monitor your speed,”

“Those devices don’t scan below the skin, they can’t detect the angle of the device or record the correct dosage. With our InsuloSenz sensor, it’s more like having “super” cruise control on so that you can read the newspaper while driving. This technology will really free up people’s time from complicated at home medication applications and reporting.”

Life science companies can gather the real life experience of patients from nGageIT’s custom patent-pending sensors to measure medication treatment effectiveness and optimize clinical outcomes. This also presents an opportunity for companies to engage in value-based contracts. With over 15 trillion doses of medications in the global supply chain and a substantially related number of disconnected patients — nGageIT aims to connect them all.

“nGageIT aims to improve wellness in the healthcare ecosystem and solve the $564 billion global problem of lost pharmaceutical revenue due to non-adherence and disengaged patients,”

“We are focused on the $34 billion niche in the specialty high-value pharmaceutical market as well as the diabetic market.”

nGageIT Digital Health Solutions is currently evaluating strategic partnerships with major pharmaceutical manufacturers to commercialize its technology.

 

 

World’s First Digital Ingestible Nanoparticle “Barcode” Makes Your Medicine “Smarter”

NanoSmart health tool by nGageIT makes taking medicine a digital experience.

nGageIT Digital Health Solutions, is making medicine smarter by developing the world’s first ingestible Digital Pharmaceutical Nano Encoding technology.

Patent pending “NanoSmart” digital encoding technology uses a mobile device that can passively detect the unique fingerprint of medications when ingested and remind patients of missed or late doses through their smartphone.

Called the Noz for short, the smart tool detects food grade safe nanoparticles or “barcodes” on tablets when ingested and the unique custom biosensor decodes these from the more than 2,500 substances in the human breath. Since each person’s breath is unique, like a fingerprint, it can be used as an identification method.

Future development of nGageIT’s biosensor technology includes the mobile detection of selected disease biomarkers from the breath, as well as as well as individualized data on how each person’s body deals with targeted medications.

Every time medication is ingested, the Noz’s biosensor identifies the tablet, the dose and other information, such as expiry date. This information is automatically mapped to the cloud and sent to the patient’s doctor and others in their health circle that they choose. This powerful data empowers physicians to easily and precisely customize therapy to the patient’s lifestyle, their behavior and their genes.

For pharmaceutical manufacturers, the technology can easily be applied to current inventory to minimize supply chain disruption.

Life Science companies and physicians gather this real life experience of patients from nGageIT’s custom patent-pending sensors to measure medication treatment effectiveness and optimize clinical outcomes. nGageIT Digital Health Solutions is currently evaluating strategic partnerships with major pharmaceutical manufacturers to commercialize its technology.

Says co-founder Dr Jennifer Murdoch, an expert in health systems, “nGageIT aims to improve wellness in the healthcare ecosystem and solve the $564 billion global problem of lost pharma revenue due to non-adherence and disengaged patients. We are focused on the $34 billion niche in Specialty High Value Pharmaceutical market as well as the diabetic market”.

“Low Medication Adherence is arguably the most significant problem in our health care eco-system, costing over $300 billion dollars in the USA alone and leading to over 125,000 premature deaths,”

“this is an opportunity to truly tailor therapy to individual patients using digital medicine”

The NanoSmart oral encoding platform key features:

  • NanoSmart turns any approved oral dosage form into a digital object
  • A custom biosensor detects from the breath the digitally encoded nanoparticles ‘like an ingestible barcode’
  • Food Grade Safe NanoSmart particles create unique detectable ingestible nanocodes for any oral medication
  • No external sensors needed for patients to wear for detection – simply breathe
  • Mobile detection device the “Noz” works through your smartphone
  • A companion app provides information on dosage and automated reminders
  • For further support patients can connect with practitioners through video or live chat
  • NanoSmart encoding particles can be safely integrated into current oral dosage form coatings used by pharmaceutical manufacturers which minimizes supply chain disruption.

 

 

World’s First Connected Injector Non-Invasively Detects Insulin Below the Skin

Smart health tools by nGageIT allow diabetic insulin users and others to ‘Inject, Detect and Go’.

 

 

A revolutionary smart injection device is in development by a new digital medicine startup company, nGageIT Digital Health Solutions. The device safely and automatically detects insulin

in and other injectable medications after injection below the skin and connects to the cloud through your smartphone. Patients using injections like insulin can simply inject, detect and go freeing them up while nGageIT automatically tracks and updates their doses.

The patent-pending iSENZ platform is the world’s first digital medication injection system which accurately administers, and non-invasively detects, the injection of any injectable subcutaneous medications below the skin, as well as correcting the angle of injection to prevent complications through real-time gyroscopic technology.

The iSENZ can be specially customized for insulin dependent diabetic patients and is called the InsuloSenz. For example, rapid insulin and other medications need to be injected either at 90 degrees or 45 degrees – suboptimal techniques lead to poor outcomes and complications. Insulosenz also has the technology to detect optimal injection sites for diabetics.

With the InsuloSenz diabetic insulin patients are free to inject, detect and go. Technology automatically detects and tracks the type of insulin injected and the time of injection through the cloud and sends the information to the patient’s smartphone. There is no change to the patient’s injecting behavior required.

Physicians and Life Science companies gather this real life experience of patients from nGageIT’s custom patent-pending sensors to measure medication treatment effectiveness and optimize clinical outcomes. nGageIT Digital Health Solutions is currently evaluating strategic partnerships with major pharmaceutical manufacturers and health systems to commercialize its technology.

With around 1.4 million new cases of diabetes diagnosed each year in the US, smart tools like the iSENZ and the InsuloSenz are expected to improve health outcomes by helping diabetic patients inject with confidence.

Says co-founder Dr Jennifer Murdoch, a nurse and an expert in health systems,

nGageIT aims to improve wellness in the healthcare ecosystem and solve the $564 billion global problem of lost pharma revenue due to non-adherence and disengaged patients. We are focused on the $34 billion niche in Specialty High Value Pharmaceutical market as well as the diabetic market.

Low Medication Adherence is arguably the most significant problem in our health care eco-system costing over $300 billion dollars in the USA alone and leading to over 125,000 premature deaths”.

Studies show that poor technique and missed doses lead to poor clinical outcomes and serious complications even in experienced users. Diabetics and other injectable medicine users lead busy lives and need smart diabetic care tools to improve their health and wellness.

A simple connection to the cloud is not enough anymore and nGageIT’s smart injection devices go beyond the connection to facilitate “real-time” disease state care by automated injection detection and real time injection technique correction,”

iSenz and InsuloSenz key features:

  • Detects and verifies the injection of medication after it is injected below the skin in a novel non-invasive manner
  • Diabetic insulin patients are free to inject, detect and go with doses automatically uploaded to the cloud and tracked. Facilitates opportunities for enhanced diabetic care.
  • Can detect the angle of injection to prevent complication and common errors
  • Patient can see the angle of injection of the drug is correct by the iSENZ flashing blue
  • Patient can see the angle of the injection is incorrect by the iSENZ flashing red
  • Clearly displays time, dose and medication and automatically uploads the data to the cloud. Facilitates “Inject, Detect and Go”
  • Easily and conveniently charged using a wireless charger
  • iSenz and Insulosenz sensor technology can be integrated into current injectable devices through co-development with manufacturer partnerships
  • iSenz technology can be used with any subcutaneously injected medication.

About nGageIT Digital Health Solutions

nGageIT Digital Health Solutions (ngageittec.com) makes medicine smarter using NanoSmart ingestible encoding technology and injection sensors to turn any drug into a digital object. Physicians use the real life experience of patients gathered from nGageIT’s sensors to optimize clinical outcomes.

For more information please contact  info@ngageittec.com

Strategic Alliances:

nGageIT has built a strong base of custom connected nanosmart drug sensor and mobile remote monitoring technologies that verify the ingestion of oral medication or detect the injection of injectable medications which addresses more than 90% of the take-home medication market. nGageIT intends to work with strategic partners to strengthen its pipeline of molecules it monitors and services. nGageIT controls key technologies with relevance outside our core business area and these we may out-license or co-develop with suitable partners. Strategic Alliances strengthen nGageIT’s pipeline of molecules to monitor and generate new collaborations and revenues. For strategic partners, nGageIT technologies give our partners an unique advantage in the competitive specialty markets to improve clinical outcomes, empower physicians and truly improve medication adherence and persistence. Further, the addition of real life and real time ingestion or injection data from the patients homes is invaluable. The combination of nGageIT ingestion and injection verification sensor technologies can also create improved value models when approaching payors for key molecules in your portfolio. Once patients are connected through their medications to the digital space, customized care services can also be easily introduced. 

Co-Development with pharmaceutical partners:

nGageIT may be interested in co-developing aspects of relevant technologies that correspond to in-house needs and partner goals. These partnerships might occur on a one-to-one basis, or a consortium approach might be considered for a relevant molecule or disease-state portfolio.

For strategic partnership opportunities contact info@ngageittec.com